Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm
Clinical Cardiology · 2024
DOI: 10.1002/clc.70004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Shozo Sueda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Minami Matsuyama Hospital, Matsuyma City, Ehime, Japan. Hauptthemen laut MEDLINE: Coronary Vasospasm, Ergonovine, Acetylcholine, Vasodilator Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Vasoreactivity testing, such as intracoronary acetylcholine (ACh) or ergometrine (EM), is defined as Class I for the diagnosis of patients with vasospastic angina (VSA) according to recommendations from the Coronary Vasomotion Disorders International Study (COVADIS) group and guidelines from the Japanese Circulation Society (JCS). Hypothesis Although vasoreactivity testing is a clinically useful tool, it carries some risks and limitations in diagnosing coronary artery spasm.
Methods
Previous reports on vasoreactivity testing for diagnosing the presence of coronary spasm are summarized from the perspective of Class I.
Results
There are several problems such as reproducibility, underestimation, overestimation, and inconclusive/nonspecific results associated with daily spasm. Because provoked spasm caused by intracoronary ACh is not always similar to that caused by intracoronary EM, possibly due to different mediators, supplementary use of these vasoreactivity tests is necessary for cardiologists to diagnose VSA when a provoked spasm is not revealed by each vasoactive agent.
Conclusions
Cardiologists should understand the imperfection of these vasoreactivity tests when diagnosing patients with VSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Minami Matsuyama Hospital, Matsuyma City, Ehime, Japan.
- Department of Cardiology, Ehime Prefectural Niihama Hospital, Niihama, Ehime, Japan.
- Department of Cardiology, Ehime University Graduate School of Medicine, Touon-shi, Ehime, Japan.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Sueda, S., Hayashi, Y., Ono, H., Okabe, H., Sakaue, T., & Ikeda, S. (2024). Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm. Clinical Cardiology. https://doi.org/10.1002/clc.70004
Vancouver
Sueda S, Hayashi Y, Ono H, Okabe H, Sakaue T, Ikeda S. Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm. Clinical Cardiology. 2024. doi:10.1002/clc.70004
BibTeX
@article{Sueda2024,
author = {Sueda, Shozo and Hayashi, Yutaka and Ono, Hiroki and Okabe, Hikaru and Sakaue, Tomoki and Ikeda, Shuntaro},
title = {Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm},
journal = {Clinical Cardiology},
year = {2024},
doi = {10.1002/clc.70004}
}
EUVIMED